According to reports from American, diabetes company Medtronic Inc is upping their investment in diabetes . The company is increasingly looking to boost levels of people with diabetes who use insulin pumps and continuous glucose monitors .
Medtronic are the largest stand-alone medical device manufacturer in the world. The company is looking to increase diabetes technology spend by 35 per cent this year, the aim being to create next-generation devices that are easier to use and manage diabetes more efficiently.
Two exciting new products that are expected to be approved soon include an insulin pump with a safety feature that shuts off insulin delivery when blood sugar goes too low, and an insulin ‘patch’ pump to eliminate pump tubing.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…